已收盤 05-22 16:00:00 美东时间
+0.490
+5.69%
今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元
05-06 11:29
RBC Capital analyst Arun Viswanathan reiterates GrafTech International (NYSE:EAF) with a Sector Perform and maintains $10 price target.
05-05 22:59
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从28美元升至49美元;HC Wainwright & Co.:维持Fate Therapeutics"买入"评级,目标价从5美元升至7美元
05-05 11:40
Graftech Intl (($EAF)) has held its Q1 earnings call. Read on for the main high...
05-02 08:16
Companies Reporting Before The Bell • WisdomTree (NYSE:WT) is projected to repo...
05-01 19:11
GrafTech Q1 sales rise 12%, beat estimates on higher volume Overview US graphite electrode maker's Q1 sales rose 12% yr/yr, beating analyst expectations Company posted wider net loss as lower realized prices offset higher sales volume GrafTech reaffirmed full-year volume and cost guidance, pursuing
05-01 18:47
GrafTech International (NYSE:EAF) reported quarterly losses of $(2.05) per share which missed the analyst consensus estimate of $(1.41) by 45.39 percent. This is a 55.3 percent decrease over losses of $(1.32) per share
05-01 18:43
GrafTech Q1 FY26 net loss widens to $43 million; net sales rise 12% to $125 million GrafTech posted a first-quarter 2026 net loss of USD 43 million, equal to USD 1.66 per share. Net sales rose 12% to USD 125 million. Adjusted EBITDA widened to a loss of USD 14 million. Sales volume climbed 14% to 28
05-01 18:40
JP Morgan analyst Bill Peterson downgrades GrafTech International (NYSE:EAF) from Neutral to Underweight.
04-14 20:12